Navigation Links
LUMEDX and Mennen Medical(R) Announce Agreement for a Strategic Cooperation
Date:3/16/2009

OAKLAND, Calif., HORSHAM, Pa. and TEL AVIV, Israel, March 16 /PRNewswire/ -- LUMEDX Corporation & Mennen Medical(R) announced today the signing of a strategic partnership agreement to provide a total, integrated cath lab data solution and seamless stream of hemodynamic cardiovascular patient data to their customers.

LUMEDX is a leading cardiovascular information system and PACS provider serving more than 500 hospitals worldwide. With a presence in over 50 countries worldwide, Mennen Medical is a leading provider of patient monitoring, hemodynamic monitoring systems and electrophysiology recording systems.

The agreement is part of both companies' desire to complement their individual product lines so that their mutual customers will enjoy a consolidated cath lab solution. Combining the cutting-edge CVIS and PACS software modalities of LUMEDX with Mennen Medical's full suite of hardware products for the cath lab, including its new state-of-the-art hemodynamic system - the Horizon XVu, its patient monitoring and its EP recording systems into one integrated system will provide a unique market solution.

This partnership will help heart centers to perform cath lab procedures, using an efficient and flexible workflow and continuous clinical patient data from the holding area, throughout the procedure room and into the recovery room.

Mennen Medical's new XVu System is embedded with an ultra modern interface and analysis system. Combined with user-friendly windows and an intuitive graphic interface, the system enables various layouts to suit both cardiac and peripheral angiography procedures, including the most advanced pediatric package that is available in the market.

Mennen Medical's proprietary front-end vital signs acquisition unit, the CFE, with its exceptionally small size, allows it to be rail-mounted on the procedure table for maximum space utilization and comfort. It employs the latest technology available and is designed to operate under the demanding workload conditions that exist in both the Cardiac and peripheral angiography environments while offering very high reliability.

"This strategic partnership between LUMEDX and Mennen Medical will provide cath labs with the widest and strongest integrated data solution that is currently offered in the U.S. market and it takes advantage of the different technologies that exists in each of the companies," said Ms. Angelia Adzic, President of Mennen Medical in the U.S. "We hope that the next stage of this partnership will be to take this powerful solution global," Ms. Adzic added.

The LUMEDX CardioStar(TM) Cardiovascular Information System (CVIS) provides a complete data and image management environment for cardiology, cardiac surgery and vascular medicine. Built around the industry-leading Apollo Advance(TM) clinical data repository, the CardioStar application suite offers physician reporting, image archiving, scheduling, inventory control, charge capture and data analytics. In addition, the company's new HealthView Network provides a community-wide information infrastructure, allowing physicians to access the complete cardiovascular hospitalization record in home or office from any internet-connected computing device.

According to Allyn D. McAuley, CEO of LUMEDX, "Medicine has long been hampered by disconnected information silos, a need now being addressed aggressively by the recently enacted economic Recovery Act. Mennen and LUMEDX have partnered to address one of the most critical information areas-the diagnostic and invasive cardiovascular cath lab-with a solution that unites all forms of clinical and administrative information in a seamless web. Caregivers and administrators will enjoy ubiquitous access to the most granular cath lab information and images, under single sign-on, within the hospital or in the ambulatory setting."

ABOUT Mennen Medical(R)

Mennen Medical(R) is a leading international corporation, developing and marketing cardiac catheterization and electrophysiology systems as well as patient monitoring and clinical data information solutions. For over four decades, Mennen Medical has led these fields worldwide, combining cutting-edge technological achievements with an uncompromising corporate culture of passionate customer service and personalized care. Mennen Medical(R) is a privately owned company with offices and agents in more than 50 countries world wide.

Mennen Medical's R&D team includes top level engineers, scientists and programmers dedicated to addressing the changing and rapidly evolving needs of these markets. Furthermore, the company benefits greatly from its substantial international presence and close links with hundreds of hospitals across the globe.

Visit Mennen Medical at www.mennenmedical.com

ABOUT LUMEDX

With more than 500 heart center clients in the U.S., LUMEDX is the market leader in fully integrated cardiovascular imaging and information systems and the fastest growing cardiology PACS solutions provider. LUMEDX offers the most proven, comprehensive package of clinical information tools, cardiovascular products and services to help medical institutions enhance quality of patient care, reduce costs, streamline workflow, increase patient volume and grow revenue.

Visit LUMEDX at www.lumedx.com.


'/>"/>
SOURCE LUMEDX Corporation
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. LUMEDX Introduces Next Generation Cardiology PACS Solution
2. Cardiac Science Announces Data Connectivity with LUMEDX
3. NDC Completes Acquisition of Phase One Medical(R) Anchoring Technology
4. Birdstep Technology Announces The Dual Upcoming Release Of Its Raima Database Manager Products
5. Patient Placement Systems Announces Free 30-Day Trial Program for Referral Management System
6. China Nepstar Chain Drugstore Announces Dividend
7. Rubbo Art of Energy Announces the Release of Their Free eBook Extraordinary Breath, to Celebrate the Start of Healthcare Reform
8. Health Career Agents Announces Three Options for Involvement in Health Care Recruiting and Staffing
9. ULURU Inc. Announces Appointment of Jeffrey A. Niezgoda, M.D., as Chairman of Scientific Advisory Board
10. MedQuist Announces Resolution of SEC Investigation
11. NCCN Announces Updates to Pancreatic Adenocarcinoma Guidelines
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... ... ... legally blind and certified personal trainer is helping to develop a weight loss fitness plan ... fix the two major problems leading the fitness industry today:, , ... They don’t eliminate all the reasons people quit their exercise program ...
(Date:6/25/2016)... TX (PRWEB) , ... June 25, 2016 , ... Austin ... of the American College of Mohs Surgery and to Dr. Russell Peckham for medical ... and highly effective treatment for skin cancer. The selective fellowship in Mohs Micrographic Surgery ...
(Date:6/25/2016)... ... 25, 2016 , ... First Choice Emergency Room , the largest network ... the Medical Director of its new Mesquite-Samuell Farm facility. , “We are pleased ... location,” said Dr. James M. Muzzarelli, Executive Medical Director of First Choice Emergency Room. ...
(Date:6/25/2016)... ... June 25, 2016 , ... On Friday, June 10, Van ... Wellness at Work award to iHire in recognition of their exemplary accomplishments in worksite ... 7th annual Maryland Workplace Health & Wellness Symposium at the BWI Marriott in Linthicum ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... Those who ... with these feelings, many turn to unhealthy avenues, such as drug or alcohol abuse, ... Marne, Michigan, has released tools for healthy coping following a traumatic event. , Trauma ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... , June 23, 2016 Research and ... Global Market - Forecast to 2022" report to their ... treatment method for the patients with kidney failure, it replaces ... fluid from the patient,s blood and thus the treatment helps ... and chloride in balance. Increasing number of ...
(Date:6/23/2016)... Research and Markets has announced the addition ... Chemical (Sugar, Petrochemical, Glycerin), Inorganic Chemical), Functionality (Filler, Binder, ... Forecast to 2021" report to their offering. ... excipients market is projected to reach USD 8.1 Billion ... forecast period 2016 to 2021. The ...
(Date:6/23/2016)... Roche (SIX: RO, ROG; OTCQX: RHHBY) announced ... BRAHMS PCT (procalcitonin) assay as a dedicated testing solution ... this clearance, Roche is the first IVD company in ... sepsis risk assessment and management. PCT is ... levels in blood can aid clinicians in assessing the ...
Breaking Medicine Technology: